Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma

被引:16
|
作者
Xu, Ziwu [1 ,2 ]
Pei, Chaozhu [2 ]
Cheng, Haojie [2 ]
Song, Kaixin [1 ]
Yang, Junting [1 ]
Li, Yuhang [1 ]
He, Yue [1 ]
Liang, Wenxuan [1 ]
Liu, Biyuan [3 ]
Tan, Wen [4 ]
Li, Xia [5 ]
Pan, Xue [1 ]
Meng, Lei [1 ]
机构
[1] Hunan Univ Chinese Med, Sch Pharm, Changsha, Peoples R China
[2] Hunan Univ, Coll Biol, Changsha, Peoples R China
[3] Hunan Univ Chinese Med, Sch Med, Changsha, Peoples R China
[4] Changsha Hosp Tradit Chinese Med, Changsha Hosp 8, Dept Pathol, Changsha, Peoples R China
[5] Peoples Hosp Hunan Prov, Dept Gen Surg, Changsha, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
FoxM1; hepatocellular carcinoma; immune infiltration; m6A modification; glycolysis; TRANSCRIPTION FACTORS; CELL-PROLIFERATION; CANCER; EXPRESSION; HALLMARKS; TARGETS; PLAYERS; ROLES;
D O I
10.3389/fimmu.2023.1138524
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundForkhead box M1 (FOXM1) is a member of the Forkhead box (Fox) transcription factor family. It regulates cell mitosis, cell proliferation, and genome stability. However, the relationship between the expression of FOXM1 and the levels of m6a modification, immune infiltration, glycolysis, and ketone body metabolism in HCC has yet to be fully elucidated. MethodsTranscriptome and somatic mutation profiles of HCC were downloaded from the TCGA database. Somatic mutations were analyzed by maftools R package and visualized in oncoplots. GO, KEGG and GSEA function enrichment was performed on FOXM1 co-expression using R. We used Cox regression and machine learning algorithms (CIBERSORT, LASSO, random forest, and SVM-RFE) to study the prognostic value of FOXM1 and immune infiltrating characteristic immune cells in HCC. The relationship between FOXM1 and m6A modification, glycolysis, and ketone body metabolism were analyzed by RNA-seq and CHIP-seq. The competing endogenous RNA (ceRNA) network construction relies on the multiMiR R package, ENCORI, and miRNET platforms. ResultsFOXM1 is highly expressed in HCC and is associated with a poorer prognosis. At the same time, the expression level of FOXM1 is significantly related to the T, N, and stage. Subsequently, based on the machine learning strategies, we found that the infiltration level of T follicular helper cells (Tfh) was a risk factor affecting the prognosis of HCC patients. The high infiltration of Tfh was significantly related to the poor overall survival rate of HCC. Besides, the CHIP-seq demonstrated that FOXM1 regulates m6a modification by binding to the promoter of IGF2BP3 and affects the glycolytic process by initiating the transcription of HK2 and PKM in HCC. A ceRNA network was successfully obtained, including FOXM1 - has-miR-125-5p - DANCR/MIR4435-2HG ceRNA network related to the prognosis of HCC. ConclusionOur study implicates that the aberrant infiltration of Tfh associated with FOXM1 is a crucial prognostic factor for HCC patients. FOXM1 regulates genes related to m6a modification and glycolysis at the transcriptional level. Furthermore, the specific ceRNA network can be used as a potential therapeutic target for HCC.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma
    Li Chen
    Weijie Zou
    Lei Zhang
    Huijuan Shi
    Zhi Li
    Caifang Ni
    Medical Oncology, 2021, 38
  • [32] Analysis of the role of m6A and lncRNAs in prognosis and immunotherapy of hepatocellular carcinoma
    Xu, Yan
    Liu, Rong
    HELIYON, 2022, 8 (09)
  • [33] Metabolic regulation of FoxM1 transcription factor by mevalonate-Rho pathways in human hepatocellular carcinoma
    Ogura, Satoshi
    Yoshida, Yuichi
    Kurahashi, Tomohide
    Egawa, Mayumi
    Furuta, Kunimaro
    Kiso, Shinichi
    Kamada, Yoshihiro
    Hikita, Hayato
    Tatsumi, Tomohide
    Takehara, Tetsuo
    HEPATOLOGY, 2016, 64 : 248A - 248A
  • [34] Mevalonate pathway targets FoxM1 transcription factor via protein geranylgeranylation in human hepatocellular carcinoma
    Ogura, Satoshi
    Yoshida, Yuichi
    Egawa, Mayumi
    Kurahashi, Tomohide
    Furuta, Kunimaro
    Kiso, Shinichi
    Kamada, Yoshihiro
    Takehara, Tetsuo
    HEPATOLOGY, 2015, 62 : 1169A - 1169A
  • [35] Comprehensive analysis of m6A RNA methylation regulators in esophageal carcinoma
    Yang, Hongzhao
    Liu, Jianbo
    Li, Li
    Wang, Xiaodong
    Li, Zhigui
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (01) : 381 - 393
  • [36] Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells
    Mikhail S. Chesnokov
    Marianna Halasi
    Soheila Borhani
    Zarema Arbieva
    Binal N. Shah
    Rick Oerlemans
    Irum Khan
    Carlos J. Camacho
    Andrei L. Gartel
    Cell Death & Disease, 12
  • [37] Identification of lncRNA biomarkers in hepatocellular carcinoma by comprehensive analysis of the lncRNA-mediated ceRNA network
    Ye, Dingde
    Liu, Yaping
    Chen, Yanuo
    Li, Guoqiang
    Sun, Beicheng
    Peng, Jin
    Xu, Qingxiang
    FRONTIERS IN GENETICS, 2022, 13
  • [38] Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells
    Chesnokov, Mikhail S.
    Halasi, Marianna
    Borhani, Soheila
    Arbieva, Zarema
    Shah, Binal N.
    Oerlemans, Rick
    Khan, Irum
    Camacho, Carlos J.
    Gartel, Andrei L.
    CELL DEATH & DISEASE, 2021, 12 (07)
  • [39] Comprehensive analysis of m6A subtype classification for immune microenvironment of pituitary adenomas
    Yuan, Feng
    Cai, Xiangming
    Wang, Yingshuai
    Du, Chaonan
    Cong, Zixiang
    Zeng, Xinrui
    Tang, Chao
    Ma, Chiyuan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124
  • [40] Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma
    Ding, Lin
    Yu, Qian
    Yang, Shuo
    Yang, Wen-Jing
    Liu, Te
    Xian, Jing-Rong
    Tian, Tong-Tong
    Li, Tong
    Chen, Wei
    Wang, Bei-Li
    Pan, Bai-Shen
    Zhou, Jian
    Fan, Jia
    Yang, Xin-Rong
    Guo, Wei
    FRONTIERS IN IMMUNOLOGY, 2022, 13